Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Pneumocystis carinii Pneumonia prophylaxis with...
Journal article

Pneumocystis carinii Pneumonia prophylaxis with atovaquone in trimethoprim‐sulfamethoxazole–intolerant orthotopic liver transplant patients: A preliminary study

Abstract

Pneumocystis carinii pneumonia (PCP) is an opportunistic infection associated with increased morbidity and mortality in solid-organ and bone-marrow transplant recipients. Side effects of trimethoprim-sulfamethoxazole (TMP/SMX) are frequent; therefore, we performed a preliminary study using atovaquone suspension, 750 mg once daily, for 1 year for the prevention of PCP in liver transplant recipients intolerant to TMP/SMX therapy. Twenty-eight …

Authors

Meyers B; Borrego F; Papanicolaou G

Journal

Liver Transplantation, Vol. 7, No. 8, pp. 750–751

Publisher

Wolters Kluwer

Publication Date

August 2001

DOI

10.1053/jlts.2001.26433

ISSN

1527-6465